Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 7 | ₹23,760 |
| 2 | Schedule 2 | VINOD AGENCIES | 1 | ₹1,020 |
| 3 | Schedule 3 | EVAAN LIFESCIENCES PRIVATE LIMITED | 1 | ₹2,200 |
| 4 | Schedule 4 | SRI SAI AGENCIES | 1 | ₹2,574 |
| 5 | Schedule 5 | VINOD AGENCIES | 1 | ₹603 |
Tender Value
₹49,149
EMD Value
Exempted
Closing Date
5 Oct 2024, 10:00 amClosed
Drugs and Pharamceutical Products
6899334
GEM/2024/B/5394652
Two Packet Bid
Mircera 100 micrograms 0.3 ml methoxy polyethylene glycol epoetin beta,Tab Rivaroxaban 2.5 mg,Tab C
15 days
Uttarakhand; Pithoragarh
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹31
50%
Exempted
5 Oct 2024
13 Sept 2024
5 Oct 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Mircera 100 micrograms 0.3 ml methoxy polyethylene glycol epoetin beta | 6 | Amp | PITHORAGARH | 15 |
| 2 | Tab Rivaroxaban 2.5 mg | 600 | No | PITHORAGARH | 15 |
| 3 | Tab Cetrizine 5 10 mg plus paracetamol 350 mg plus pseudoephedrine 30 60 mg common cold | 4,000 | No | PITHORAGARH | 15 |
| 4 | Doxophyllin 400 mg tab | 1,800 | No | PITHORAGARH | 15 |
| 5 | Gliclazide XR 60 mg tab | 450 | No | PITHORAGARH | 15 |
| 6 | Metronidazole 400 mg tab | 1,800 | No | PITHORAGARH | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6899334.pdf
GEM_BID
tech_bd_2024-09-13-09-24-50_ed9ce1afe278c4532000c8418bb7cdde.pdf
BOQ
boq_item_sample_file_2024-09-13-09-24-50_6fb249faaba02bdeab9db5566c74765b.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .